Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

SHE:300639 Revenue

Guangdong Hybribio Biotech had revenue of 170.88M CNY in the quarter ending September 30, 2025, a decrease of -15.14%. This brings the company's revenue in the last twelve months to 691.16M, down -20.01% year-over-year. In the year 2024, Guangdong Hybribio Biotech had annual revenue of 815.53M, down -26.16%.

• Revenue (ttm): 691.16M
• Revenue Growth: -20.01%
• P/S Ratio: 6.48
• Revenue / Employee: 313.45K
• Employees: 2,205
• Market Cap: 4.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	815.53M	-288.93M	-26.16%
Dec 31, 2023	1.10B	-4.49B	-80.27%
Jan 1, 2023	5.60B	2.92B	109.39%
Jan 1, 2022	2.67B	1.32B	97.34%
Dec 31, 2020	1.35B	625.10M	85.70%